X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (574) 574
oncology (389) 389
female (336) 336
index medicus (336) 336
chemotherapy-induced anemia (309) 309
cancer (284) 284
middle aged (279) 279
male (268) 268
aged (238) 238
chemotherapy (233) 233
double-blind (192) 192
adult (189) 189
quality-of-life (181) 181
anemia (178) 178
antineoplastic agents - adverse effects (161) 161
recombinant-human-erythropoietin (157) 157
anemia - drug therapy (155) 155
antineoplastic combined chemotherapy protocols - adverse effects (138) 138
neoplasms - drug therapy (137) 137
erythropoietin - therapeutic use (136) 136
medicine & public health (130) 130
anemia - chemically induced (121) 121
hematology (118) 118
antineoplastic combined chemotherapy protocols - therapeutic use (112) 112
neoplasms - complications (112) 112
care and treatment (111) 111
quality of life (109) 109
epoetin-alpha (104) 104
recombinant proteins (104) 104
anemia - etiology (102) 102
hematinics - therapeutic use (102) 102
erythropoietin (96) 96
aged, 80 and over (92) 92
pharmacology & pharmacy (92) 92
treatment outcome (92) 92
placebo-controlled trial (91) 91
retrospective studies (87) 87
darbepoetin alfa (77) 77
cancer-patients (76) 76
erythropoiesis-stimulating agents (74) 74
neutropenia (73) 73
colony-stimulating factor (71) 71
drug administration schedule (71) 71
hemoglobin (71) 71
antineoplastic agents - therapeutic use (69) 69
breast cancer (67) 67
risk factors (67) 67
darbepoetin-alpha (65) 65
erythropoietin - analogs & derivatives (65) 65
analysis (62) 62
cancer patients (62) 62
chemotherapy-induced neutropenia (62) 62
health care sciences & services (61) 61
therapy (61) 61
breast-cancer (58) 58
epoetin alfa (57) 57
fatigue (57) 57
survival (57) 57
febrile neutropenia (56) 56
breast neoplasms - drug therapy (55) 55
cell lung-cancer (53) 53
neutropenia - chemically induced (53) 53
research (53) 53
nursing (52) 52
erythropoietin - administration & dosage (51) 51
non-hodgkins-lymphoma (51) 51
trial (51) 51
blood transfusion (49) 49
adolescent (48) 48
lung neoplasms - drug therapy (48) 48
drug therapy (47) 47
health aspects (47) 47
management (46) 46
animals (45) 45
rehabilitation (45) 45
prevention (44) 44
anemia - therapy (43) 43
cancer therapies (43) 43
chemotherapy-induced nausea (43) 43
pain medicine (43) 43
dose-response relationship, drug (42) 42
rehabilitation medicine (42) 42
anaemia (41) 41
prospective studies (41) 41
antineoplastic combined chemotherapy protocols - administration & dosage (40) 40
neoplasms - blood (40) 40
prognosis (40) 40
receiving chemotherapy (40) 40
clinical trials as topic (39) 39
lung cancer (39) 39
nausea (39) 39
neoplasm staging (39) 39
survival rate (39) 39
cisplatin - administration & dosage (38) 38
efficacy (38) 38
intravenous iron (38) 38
transfusion (38) 38
community oncology (37) 37
medicine, general & internal (37) 37
safety (37) 37
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (649) 649
Japanese (58) 58
French (24) 24
Chinese (17) 17
German (7) 7
Spanish (5) 5
Hungarian (3) 3
Italian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Therapeutics, ISSN 0149-2918, 2016, Volume 38, Issue 1, pp. 122 - 135.e6
Journal Article
Cancer Science, ISSN 1347-9032, 12/2014, Volume 105, Issue 12, pp. 1569 - 1575
The aim of the current study is to evaluate the prognostic value of anemia, an easily estimable parameter in patients with diffuse large B‐cell lymphoma... 
non‐Hodgkin's lymphoma | diffuse large B‐cell lymphoma | Anemia | prognosis | biomarkers | Biomarkers | Prognosis | Non-Hodgkin's lymphoma | Diffuse large B-cell lymphoma | CHEMOTHERAPY-INDUCED ANEMIA | ALPHA | DEATH | diffuse large B-cell lymphoma | PARAMETERS | CANCER | THERAPY | ONCOLOGY | non-Hodgkin's lymphoma | NEUTROPENIA | RITUXIMAB | NON-HODGKINS-LYMPHOMA | Doxorubicin - therapeutic use | Multivariate Analysis | Anemia - blood | Humans | Middle Aged | Male | Cyclophosphamide - therapeutic use | Young Adult | Aged, 80 and over | Adult | Female | Neoplasm Recurrence, Local - blood | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Anemia - chemically induced | Treatment Outcome | Neoplasm Recurrence, Local - diagnosis | Biomarkers, Tumor - blood | Disease-Free Survival | Anemia - complications | Lymphoma, Large B-Cell, Diffuse - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Aged | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Antimitotic agents | Care and treatment | Chemotherapy | Hemoglobin | Lymphomas | Antineoplastic agents | Cancer | Cytokines | Rituximab | Iron | Radiation therapy | Multivariate analysis | Cancer therapies | Doxorubicin | Vincristine | Patients | Lymphoma | Blood | Clinical outcomes | Cyclophosphamide | Lymphocytes B | Medical prognosis | Bone marrow | Remission | Blood diseases | Prednisolone | Original
Journal Article
Journal Article